163 related articles for article (PubMed ID: 37255411)
1. Overlaid Transcriptional and Proteome Analyses Identify Mitotic Kinesins as Important Targets of Arylsulfonamide-Mediated RBM39 Degradation.
Coomar S; Mota P; Penson A; Schwaller J; Abdel-Wahab O; Gillingham D
Mol Cancer Res; 2023 Aug; 21(8):768-778. PubMed ID: 37255411
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.
Bussiere DE; Xie L; Srinivas H; Shu W; Burke A; Be C; Zhao J; Godbole A; King D; Karki RG; Hornak V; Xu F; Cobb J; Carte N; Frank AO; Frommlet A; Graff P; Knapp M; Fazal A; Okram B; Jiang S; Michellys PY; Beckwith R; Voshol H; Wiesmann C; Solomon JM; Paulk J
Nat Chem Biol; 2020 Jan; 16(1):15-23. PubMed ID: 31819272
[TBL] [Abstract][Full Text] [Related]
3. Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.
Singh S; Quarni W; Goralski M; Wan S; Jin H; Van de Velde LA; Fang J; Wu Q; Abu-Zaid A; Wang T; Singh R; Craft D; Fan Y; Confer T; Johnson M; Akers WJ; Wang R; Murray PJ; Thomas PG; Nijhawan D; Davidoff AM; Yang J
Sci Adv; 2021 Nov; 7(47):eabj5405. PubMed ID: 34788094
[TBL] [Abstract][Full Text] [Related]
4. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
Han T; Goralski M; Gaskill N; Capota E; Kim J; Ting TC; Xie Y; Williams NS; Nijhawan D
Science; 2017 Apr; 356(6336):. PubMed ID: 28302793
[TBL] [Abstract][Full Text] [Related]
5. Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15.
Ting TC; Goralski M; Klein K; Wang B; Kim J; Xie Y; Nijhawan D
Cell Rep; 2019 Nov; 29(6):1499-1510.e6. PubMed ID: 31693891
[TBL] [Abstract][Full Text] [Related]
6. Insights on the biological functions and diverse regulation of RNA-binding protein 39 and their implication in human diseases.
Eléouët M; Lu C; Zhou Y; Yang P; Ma J; Xu G
Biochim Biophys Acta Gene Regul Mech; 2023 Mar; 1866(1):194902. PubMed ID: 36535628
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding motif protein 39 (RBM39): An emerging cancer target.
Xu Y; Nijhuis A; Keun HC
Br J Pharmacol; 2022 Jun; 179(12):2795-2812. PubMed ID: 33238031
[TBL] [Abstract][Full Text] [Related]
8. Proximity Labeling, Quantitative Proteomics, and Biochemical Studies Revealed the Molecular Mechanism for the Inhibitory Effect of Indisulam on the Proliferation of Gastric Cancer Cells.
Lu J; Jiang H; Li D; Chen T; Wang Y; Pu Z; Xu G
J Proteome Res; 2021 Sep; 20(9):4462-4474. PubMed ID: 34420308
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820.
Du X; Volkov OA; Czerwinski RM; Tan H; Huerta C; Morton ER; Rizzi JP; Wehn PM; Xu R; Nijhawan D; Wallace EM
Structure; 2019 Nov; 27(11):1625-1633.e3. PubMed ID: 31693911
[TBL] [Abstract][Full Text] [Related]
10. Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.
Faust TB; Yoon H; Nowak RP; Donovan KA; Li Z; Cai Q; Eleuteri NA; Zhang T; Gray NS; Fischer ES
Nat Chem Biol; 2020 Jan; 16(1):7-14. PubMed ID: 31686031
[TBL] [Abstract][Full Text] [Related]
11. pSILAC method coupled with two complementary digestion approaches reveals PRPF39 as a new E7070-dependent DCAF15 substrate.
Jia X; Pan L; Zhu M; Hu H; Zhai L; Liu J; Hu M; Liu B; Tan M
J Proteomics; 2020 Jan; 210():103545. PubMed ID: 31626998
[TBL] [Abstract][Full Text] [Related]
12. Global regulation of alternative RNA splicing by the SR-rich protein RBM39.
Mai S; Qu X; Li P; Ma Q; Cao C; Liu X
Biochim Biophys Acta; 2016 Aug; 1859(8):1014-24. PubMed ID: 27354116
[TBL] [Abstract][Full Text] [Related]
13. Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy.
Wolter P; Hanselmann S; Pattschull G; Schruf E; Gaubatz S
Oncotarget; 2017 Feb; 8(7):11160-11172. PubMed ID: 28061449
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between nonreceptor tyrosine kinase c-Abl and SR-Rich protein RBM39.
Mai S; Qu X; Li P; Ma Q; Liu X; Cao C
Biochem Biophys Res Commun; 2016 Apr; 473(1):355-360. PubMed ID: 27018250
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress.
Lemaitre F; Chakrama F; O'Grady T; Peulen O; Rademaker G; Deward A; Chabot B; Piette J; Colige A; Lambert C; Dequiedt F; Habraken Y
Nucleic Acids Res; 2022 Dec; 50(22):12768-12789. PubMed ID: 36477312
[TBL] [Abstract][Full Text] [Related]
16. Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal Erythropoiesis.
Huang SC; Zhang HS; Yu B; McMahon E; Nguyen DT; Yu FH; Ou AC; Ou JP; Benz EJ
Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28193846
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy.
Tong J; Xu X; Zhang Z; Ma C; Xiang R; Liu J; Xu W; Wu C; Li J; Zhan F; Wu Y; Yan H
Haematologica; 2020 Jun; 105(6):1630-1640. PubMed ID: 31289203
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Sulfonamides Induce Splicing Factor RBM39 Degradation.
Cancer Discov; 2017 May; ():. PubMed ID: 28500024
[TBL] [Abstract][Full Text] [Related]
19. Mutation of Kinesin-6 Kif20b causes defects in cortical neuron polarization and morphogenesis.
McNeely KC; Cupp TD; Little JN; Janisch KM; Shrestha A; Dwyer ND
Neural Dev; 2017 Mar; 12(1):5. PubMed ID: 28359322
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
